Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA.

Mov Disord. 2019 Feb 6. doi: 10.1002/mds.27619. [Epub ahead of print]

PMID:
30726566
2.

Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.

Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, Höglinger GU.

Mov Disord. 2013 Apr;28(4):504-9. doi: 10.1002/mds.25327. Epub 2013 Feb 21.

PMID:
23436751
3.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS.

Neurology. 1996 Jul;47(1):1-9. Review.

PMID:
8710059
4.

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.

5.

Progressive Supranuclear Palsy: an Update.

Armstrong MJ.

Curr Neurol Neurosci Rep. 2018 Feb 17;18(3):12. doi: 10.1007/s11910-018-0819-5. Review.

PMID:
29455271
6.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Review.

7.

Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.

Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T.

Parkinsonism Relat Disord. 2013 Dec;19(12):1149-51. doi: 10.1016/j.parkreldis.2013.07.019. Epub 2013 Aug 3.

PMID:
23916652
8.

Freezing of gait is an early clinical feature of progressive supranuclear palsy.

Osaki Y, Morita Y, Miyamoto Y, Furuta K, Furuya H.

Neurol Clin Neurosci. 2017 May;5(3):86-90. doi: 10.1111/ncn3.12122. Epub 2017 Apr 17.

9.
10.

Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.

Koga S, Josephs KA, Ogaki K, Labbé C, Uitti RJ, Graff-Radford N, van Gerpen JA, Cheshire WP, Aoki N, Rademakers R, Wszolek ZK, Ross OA, Dickson DW.

Mov Disord. 2016 May;31(5):653-62. doi: 10.1002/mds.26499. Epub 2016 Feb 3.

11.

Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.

Sakamoto R, Tsuchiya K, Mimura M.

Neuropathology. 2010 Feb 1;30(1):24-35. doi: 10.1111/j.1440-1789.2009.01032.x. Epub 2009 Jun 7.

PMID:
19508347
12.

Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.

Bacchi S, Chim I, Patel S.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):21-31. doi: 10.1111/1754-9485.12613. Epub 2017 Apr 22. Review.

PMID:
28432758
13.

Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.

Tilley E, McLoughlin J, Koblar SA, Doeltgen SH, Stern C, White S, Peters MD.

JBI Database System Rev Implement Rep. 2016 Jun;14(6):148-95. doi: 10.11124/JBISRIR-2016-2002352. Review.

PMID:
27532657
14.

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU.

Lancet Neurol. 2017 Jul;16(7):552-563. doi: 10.1016/S1474-4422(17)30157-6. Epub 2017 Jun 13. Review.

15.

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ.

Brain. 2001 Jul;124(Pt 7):1438-49.

PMID:
11408338
16.

Genetics of Progressive Supranuclear Palsy.

Im SY, Kim YE, Kim YJ.

J Mov Disord. 2015 Sep;8(3):122-9. doi: 10.14802/jmd.15033. Epub 2015 Sep 10. Review.

17.

A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.

Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW.

Arch Neurol. 2002 Oct;59(10):1597-601.

PMID:
12374498
18.
19.

Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?

Nigro S, Morelli M, Arabia G, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A.

Parkinsonism Relat Disord. 2017 Aug;41:31-36. doi: 10.1016/j.parkreldis.2017.05.002. Epub 2017 May 3.

PMID:
28487107
20.

The diagnosis of progressive supranuclear palsy: current opinions and challenges.

Ali F, Josephs K.

Expert Rev Neurother. 2018 Jul;18(7):603-616. doi: 10.1080/14737175.2018.1489241. Epub 2018 Jun 28. Review.

PMID:
29902389

Supplemental Content

Support Center